GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » Research & Development

MedMen Enterprises (MedMen Enterprises) Research & Development : $0.0 Mil (TTM As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. MedMen Enterprises's Research & Development for the three months ended in Mar. 2023 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 was $0.0 Mil.

MedMen Enterprises Research & Development Historical Data

The historical data trend for MedMen Enterprises's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises Research & Development Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MedMen Enterprises Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMen Enterprises  (OTCPK:MMNFQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

MedMen Enterprises Research & Development Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMen Enterprises (MedMen Enterprises) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » Research & Development
Comparable Companies
TSXV:ROMJ TSX:LABS TSXV:PCLO XCNQ:GWAY XCNQ:TRIP TSX:AVCN XCNQ:BZAM XCNQ:TIUM.U TSXV:CANB XCNQ:ACRG.A.U ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX
Traded in Other Exchanges
0JS:Germany MMEN:Canada
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
Website
https://www.medmen.com
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.